Literature DB >> 22584735

Mutations of the AMH type II receptor in two extended families with persistent Müllerian duct syndrome: lack of phenotype/genotype correlation.

Mohammad Abduljabbar1, Khalid Taheini, Jean-Yves Picard, Richard L Cate, Nathalie Josso.   

Abstract

Our goal was to compare phenotype and genotype in two extended Middle-Eastern families affected by persistent Müllerian duct syndrome due to mutations of the type II anti-Müllerian hormone receptor (AMHR-II). The first, consanguineous, family consisted of 6 boys and 2 girls, the second consisted of 4 girls and 2 boys. In family I, 4 boys and 1 girl were homozygous for a stop mutation in the 9th exon of AMHR-II, removing part of the intracellular domain of the protein. In family II, 1 girl and 1 boy were homozygous for a transversion changing conserved histidine 254 into a glutamine. Both homozygous girls were normal. In the homozygous males, the degree of development of Müllerian derivatives was variable. The uterus was well developed in 2 boys of family I and in the patient from family II; however, in 1 subject from family I, Müllerian derivatives were undetectable. Taken together, the diversity of clinical symptoms within the same sibship and the lack of correlation between the development of the Müllerian derivatives and the severity of the molecular defects suggest highly variable penetrance of the abnormal alleles and/or the existence of other genetic or epigenetic modifiers of gene expression.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584735     DOI: 10.1159/000338343

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  8 in total

Review 1.  Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.

Authors:  Niels E Skakkebaek; Ewa Rajpert-De Meyts; Germaine M Buck Louis; Jorma Toppari; Anna-Maria Andersson; Michael L Eisenberg; Tina Kold Jensen; Niels Jørgensen; Shanna H Swan; Katherine J Sapra; Søren Ziebe; Lærke Priskorn; Anders Juul
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 2.  Anti-müllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologist.

Authors:  Nathalie Josso; Rodolfo A Rey; Jean-Yves Picard
Journal:  Int J Endocrinol       Date:  2013-12-08       Impact factor: 3.257

3.  Persistent Müllerian Duct Syndrome with Transverse Testicular Ectopia: A Novel Anti-Müllerian Hormone Receptor Mutation.

Authors:  Özlem Korkmaz; Samim Özen; Nurhan Özcan; Petek Bayındır; Sait Şen; Hüseyin Onay; Damla Gökşen; Ali Avanoğlu; Ferda Özkınay; Şükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-01-17

4.  A Novel Mutation of AMHR2 in Two Siblings with Persistent Müllerian Duct Syndrome

Authors:  Edip Unal; Ruken Yıldırım; Suat Tekin; Vasfiye Demir; Hüseyin Onay; Yusuf Kenan Haspolat
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-04-24

5.  Surgical management and molecular diagnosis of persistent Müllerian duct syndrome in Chinese patients.

Authors:  Hong-Juan Tian; De-Hua Wu; Wei Ru; Ding-Wen Wu; Chang Tao; Guang-Jie Chen; Jin-Na Yuan; Jun-Fen Fu; Da-Xing Tang
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

6.  A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome.

Authors:  Jianzheng Fang; Gao Gao; Jinyong Liu; Lingbo Cai; Yugui Cui; Xiaoyu Yang
Journal:  Mol Genet Genomic Med       Date:  2021-09-04       Impact factor: 2.183

7.  Gene changes may minimize masculinizing and defeminizing influences of exposure to male cotwins in female callitrichine primates.

Authors:  Jeffrey A French; Brett Frye; Jon Cavanaugh; Dongren Ren; Aaryn C Mustoe; Lisa Rapaport; Jennifer Mickelberg
Journal:  Biol Sex Differ       Date:  2016-06-02       Impact factor: 5.027

Review 8.  What Does AMH Tell Us in Pediatric Disorders of Sex Development?

Authors:  Nathalie Josso; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-08       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.